Journal of Medicinal Chemistry · 2012 · 38 citations · 20 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryMolecular OncologyStructure-activity RelationshipsAntineoplastic Drug ClassesCancer NanomedicineOncology PharmacologyPharmacodynamics Of Anticancer AgentsStructure-activity Relationship AnalysisAnticancer ActivityAnticancer Mechanism Of ActionAntiproliferative AgentsAntiproliferative Drug ActionCancer Cell Proliferation InhibitionCell Cycle AnalysisChemical Structure-activity RelationshipsOrganometallic Anticancer Agents
In this article, we report the findings of a comprehensive structure-activity relationship study of N-(6-ferrocenyl-2-naphthoyl) dipeptide ethyl esters, in which novel analogues were designed, synthesized, and evaluated in vitro for antiproliferative effect. Two new compounds, 2 and 16, showed potent nanomolar activity in the H1299 NSCLC cell line, with exceptional IC(50) values of 0.13 and 0.14 μM, respectively. These compounds were also found to have significant activity in the Sk-Mel-28 malignant melanoma cell line (IC(50) values of 1.10 and 1.06 μM, respectively). Studies were also conducted to elucidate the mode of action of these novel organometallic anticancer compounds. Cell cycle analysis in the H1299 cell line suggests these compounds induce apoptosis, while guanine oxidation studies confirm that 2 is capable of generating oxidative damage via a ROS-mediated mechanism.
20
Application of ferrocene and its derivatives in cancer research
Cátia Ornelas · New Journal of Chemistry · 2011 · 471 citations
On the medicinal chemistry of ferrocene
M.F.R. Fouda, Mokhles M. Abd‐Elzaher, Rafeek A. Abdelsamaia et al. · Applied Organometallic Chemistry · 2007 · 458 citations
Elesclomol induces cancer cell apoptosis through oxidative stress
Jessica R. Kirshner, Suqin He, Vishwasenani Balasubramanyam et al. · Molecular Cancer Therapeutics · 2008 · 352 citations · Full text